Ensysce amends Series C preferred stock designation
Ensysce Biosciences filed a certificate of amendment to delete a provision and references for Section 6.5.3 from its Series C preferred stock designation.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed